118 related articles for article (PubMed ID: 28927903)
1. Linker structure-activity relationships in fluorodeoxyglucose chlorambucil conjugates for tumor-targeted chemotherapy.
El Hilali M; Reux B; Debiton E; Leal F; Galmier MJ; Vivier M; Chezal JM; Miot-Noirault E; Coudert P; Weber V
Bioorg Med Chem; 2017 Oct; 25(20):5692-5708. PubMed ID: 28927903
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and cytotoxic properties of new fluorodeoxyglucose-coupled chlorambucil derivatives.
Reux B; Weber V; Galmier MJ; Borel M; Madesclaire M; Madelmont JC; Debiton E; Coudert P
Bioorg Med Chem; 2008 May; 16(9):5004-20. PubMed ID: 18424156
[TBL] [Abstract][Full Text] [Related]
3. Preclinical investigation of tolerance and antitumour activity of new fluorodeoxyglucose-coupled chlorambucil alkylating agents.
Miot-Noirault E; Reux B; Debiton E; Madelmont JC; Chezal JM; Coudert P; Weber V
Invest New Drugs; 2011 Jun; 29(3):424-33. PubMed ID: 20033262
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of folate-based chlorambucil delivery systems for tumor-targeted chemotherapy.
Guaragna A; Chiaviello A; Paolella C; D'Alonzo D; Palumbo G; Palumbo G
Bioconjug Chem; 2012 Jan; 23(1):84-96. PubMed ID: 22121907
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil.
Beyer U; Roth T; Schumacher P; Maier G; Unold A; Frahm AW; Fiebig HH; Unger C; Kratz F
J Med Chem; 1998 Jul; 41(15):2701-8. PubMed ID: 9667961
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.
Gilad Y; Noy E; Senderowitz H; Albeck A; Firer MA; Gellerman G
Bioorg Med Chem; 2016 Jan; 24(2):294-303. PubMed ID: 26719208
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of DNA alkylation by conjugates between pyrrole-imidazole hairpin polyamides and chlorambucil or seco-CBI.
Minoshima M; Bando T; Shinohara K; Kashiwazaki G; Nishijima S; Sugiyama H
Bioorg Med Chem; 2010 Feb; 18(3):1236-43. PubMed ID: 20074970
[TBL] [Abstract][Full Text] [Related]
8. Fabrication of chlorambucil loaded graphene- oxide nanocarrier and its application for improved antitumor activity.
Singh G; Nenavathu BP; Imtiyaz K; Moshahid A Rizvi M
Biomed Pharmacother; 2020 Sep; 129():110443. PubMed ID: 32593130
[TBL] [Abstract][Full Text] [Related]
9.
Vats K; Satpati D; Sharma R; Kumar C; Sarma HD; Dash A
J Labelled Comp Radiopharm; 2017 Jul; 60(9):431-438. PubMed ID: 28545160
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and antitumor properties of glycosylated antitumor ether lipid (GAEL)- chlorambucil-hybrids.
Idowu T; Samadder P; Arthur G; Schweizer F
Chem Phys Lipids; 2016 Jan; 194():139-48. PubMed ID: 26188768
[TBL] [Abstract][Full Text] [Related]
11. Improvement of the Anticancer Activity of Chlorambucil and Ibuprofen via Calix[4]arene Conjugates.
Pedro-Hernández LD; Organista-Mateos U; Allende-Alarcón LI; Martínez-Klimova E; Ramírez-Ápan T; Martínez-García M
Med Chem; 2020; 16(7):984-990. PubMed ID: 31448714
[TBL] [Abstract][Full Text] [Related]
12. Protein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity.
Nazarov AA; Meier SM; Zava O; Nosova YN; Milaeva ER; Hartinger CG; Dyson PJ
Dalton Trans; 2015 Feb; 44(8):3614-23. PubMed ID: 25407500
[TBL] [Abstract][Full Text] [Related]
13. Rational design, synthesis and preliminary antitumor activity evaluation of a chlorambucil derivative with potent DNA/HDAC dual-targeting inhibitory activity.
Xie R; Li Y; Tang P; Yuan Q
Bioorg Med Chem Lett; 2017 Sep; 27(18):4415-4420. PubMed ID: 28818449
[TBL] [Abstract][Full Text] [Related]
14. Design of novel tyrosine-nitrogen mustard hybrid molecules active against uterine, ovarian and breast cancer cell lines.
Descôteaux C; Brasseur K; Leblanc V; Parent S; Asselin E; Bérubé G
Steroids; 2012 Apr; 77(5):403-12. PubMed ID: 22227028
[TBL] [Abstract][Full Text] [Related]
15. Novel melphalan and chlorambucil derivatives of 2,2,6,6-tetramethyl-1-piperidinyloxy radicals: synthesis, characterization, and biological evaluation in vitro.
Zhao H; Meng X; Yuan H; Lan M
Chem Pharm Bull (Tokyo); 2010 Mar; 58(3):332-5. PubMed ID: 20190437
[TBL] [Abstract][Full Text] [Related]
16. Polymer-Chlorambucil Drug Conjugates: A Dynamic Platform of Anticancer Drug Delivery.
Saha B; Haldar U; De P
Macromol Rapid Commun; 2016 Jul; 37(13):1015-20. PubMed ID: 27159378
[TBL] [Abstract][Full Text] [Related]
17. Alkylating agents from sugars. Alkyl hexopyranoside derivatives as carrier systems for chlorambucil.
Iglesias-Guerra F; Candela JI; Bautista J; Alcudia F; Vega-Pérez JM
Carbohydr Res; 1999 Mar; 316(1-4):71-84. PubMed ID: 10420589
[TBL] [Abstract][Full Text] [Related]
18. Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo.
Stíbal D; Therrien B; Süss-Fink G; Nowak-Sliwinska P; Dyson PJ; Čermáková E; Řezáčová M; Tomšík P
J Biol Inorg Chem; 2016 Jul; 21(4):443-52. PubMed ID: 27040952
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16.
Soler M; González-Bártulos M; Figueras E; Ribas X; Costas M; Massaguer A; Planas M; Feliu L
Org Biomol Chem; 2015 Feb; 13(5):1470-80. PubMed ID: 25474438
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro evaluation of quaternary ammonium derivatives of chlorambucil and melphalan, anticancer drugs designed for the chemotherapy of chondrosarcoma.
Giraud I; Rapp M; Maurizis JC; Madelmont JC
J Med Chem; 2002 May; 45(10):2116-9. PubMed ID: 11985479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
